Glycopyrrolate Transdermal Patch 1.5mg/day
Extended-release transdermal patch delivering 1.5mg glycopyrrolate daily for hyperhidrosis and sialorrhea via skin absorption affecting digestive glands. Form of transdermal system in measured doses under HTS 3004.90.92.57.
Import Duty Rates by Country of Origin
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If other non-specific medicaments
Ingredient-specific codes override general other categories.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Adhesive matrix testing for skin irritation compliance
• Controlled substance checks if analogs trigger DEA rules
• Shelf-life extension data for patches mandatory
Related Products under HTS 3004.90.92.57
Glycopyrrolate Oral Solution 1mg/5mL
This is a liquid oral medication containing glycopyrrolate, an anticholinergic agent used to reduce saliva production in patients undergoing surgery or with chronic drooling conditions. It falls under HTS 3004.90.92.57 as a medicament primarily affecting the digestive system, put up in measured doses for therapeutic use. The product is mixed with water or other solvents but classified as unmixed per chapter notes.
Glycopyrrolate Injection 0.2mg/mL Vial
Sterile injectable solution of glycopyrrolate used preoperatively to inhibit salivary secretions and block cardiac vagal activity. Classified under HTS 3004.90.92.57 for medicaments affecting the digestive system in measured doses. It is an unmixed product per chapter notes despite solvent dissolution.
Robinul Glycopyrrolate Tablets 1mg
Brand-name Robinul tablets containing 1mg glycopyrrolate bromide for treating peptic ulcers and reducing gastric secretions. This retail-packed medicament primarily affects the digestive system, fitting HTS 3004.90.92.57. Put up in measured doses as solid oral forms.
Glycopyrrolate Nasal Spray 0.5mg/dose
Metered-dose nasal spray formulation of glycopyrrolate for sialorrhea treatment in neurological disorders, targeting salivary glands linked to digestive function. HTS 3004.90.92.57 applies as a mixed product in measured doses for therapeutic use on digestive system.
Cuvposa Glycopyrrolate Oral Solution
Prescription Cuvposa brand oral solution with glycopyrrolate for chronic severe drooling in pediatric cerebral palsy patients. Affects digestive-related secretions; classified in HTS 3004.90.92.57 for measured-dose medicaments primarily for digestive system.
Generic Glycopyrrolate Bromide 2mg/mL Injection
Generic sterile injectable glycopyrrolate bromide used intraoperatively to dry secretions and prevent bradycardia. HTS 3004.90.92.57 covers this digestive-affecting medicament in pre-filled syringes or vials for measured administration.